HIV/AIDS Curability Study, Different Approaches and Drug Combination.

Area of Science:

• Infectious Diseases
• Virology
• Immunology
• Pharmacology

Background:

• Human Immunodeficiency Virus (HIV) infection remains an incurable disease, necessitating lifelong antiretroviral therapy.
• The precise causality and mechanisms underlying HIV's incurability are not fully understood, presenting a significant therapeutic challenge.

Purpose of the Study:

• To propose novel ideas and approaches for global HIV/AIDS therapeutic strategies.
• To explore experimental and clinical innovations aimed at achieving HIV curability.
• To provide scientific insights into overcoming current therapeutic setbacks in HIV management.

Main Methods:

• Review and synthesis of current scientific literature on HIV pathogenesis and treatment.
• Highlighting pharmaceutical characteristics, herbal medicine, and novel drug targets.
• Exploring cutting-edge biotherapy, drug combinations, animal models, and immune-stimuli for HIV latency and clearance.

Main Results:

• Identification of key areas for therapeutic advancement, including drug targets and biotherapies.
• Emphasis on the potential of immune-stimuli and combination therapies for managing HIV latency.
• Discussion of advancements in understanding HIV pathogenesis and evolution.

Conclusions:

• Novel pathological discoveries and therapeutic evolution are crucial for achieving HIV/AIDS curability.
• Translating findings from animal models to human populations is essential for widespread therapeutic breakthroughs.
• Anticipation of major advancements in medicine and drug development for infectious disease treatment.